Literature DB >> 25294892

The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads.

Jia Li1, Lihong Fan1, Zefeng Yu1, Xiaoqian Dang1, Kunzheng Wang2.   

Abstract

In this study, we examined whether local deferoxamine (DFO) administration can promote angiogenesis and bone repair in steroid-induced osteonecrosis of the femoral head (ONFH). Steroid-induced ONFH was induced in 65 mature male New Zealand white rabbits by methylprednisolone in combination with lipopolysaccharide. Six weeks later, the rabbits received no treatment (model group, N = 15), bilateral core decompression (CD group, N = 20) or CD in combination with local DFO administration (DFO group, N = 20). Six weeks after the surgery, vascularization in the femoral head was evaluated by ink artery infusion angiography and immunohistochemical staining for von Willebrand Factor (vWF). Bone repair was assessed by histologic analysis and micro-computed tomography (micro-CT). Immunohistochemical staining was performed to analyze the expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1α (HIF-1α), bone morphogenetic protein-2 (BMP-2), and osteocalcin (OCN). Ink artery infusion angiography and microvessel analysis by immuohistochemical staining for vWF showed more blood vessels in the DFO group than other groups. The expression of HIF-1α, VEGF, BMP-2, and OCN, indicated by immunohistochemical staining, was higher in the DFO group compared with other groups. Micro-CT scanning results indicated that the DFO group had larger volume of newly formed bone than the CD group. This work indicated that local DFO administration improved angiogenesis and bone repair of early stage ONFH in rabbit model, and it may offer an efficient, economic, and simple therapy for early stage ONFH.
© 2014 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Osteonecrosis; angiogenesis; bone repair; deferoxamine; hypoxia-inducible factor-1α

Mesh:

Substances:

Year:  2014        PMID: 25294892      PMCID: PMC4935312          DOI: 10.1177/1535370214553906

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  34 in total

1.  Biostructural augmentation for the treatment of osteonecrosis: rationale, technique, and case example.

Authors:  Alex Leali; Joseph Fetto; James J Hale
Journal:  J South Orthop Assoc       Date:  2002

2.  Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells.

Authors:  Reinhard Gruber; Barbara Kandler; Phillip Holzmann; Margit Vögele-Kadletz; Udo Losert; Michael B Fischer; Georg Watzek
Journal:  Tissue Eng       Date:  2005 May-Jun

3.  Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. A comparison with other diagnoses.

Authors:  K H Chiu; W Y Shen; C K Ko; K M Chan
Journal:  J Arthroplasty       Date:  1997-09       Impact factor: 4.757

4.  Increasing vascularity to improve healing of a segmental defect of the rat femur.

Authors:  Rena Stewart; Jessica Goldstein; Alan Eberhardt; Gabe Tien-Min Gabriel Chu; Shawn Gilbert
Journal:  J Orthop Trauma       Date:  2011-08       Impact factor: 2.512

5.  Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST.

Authors:  Chih-Chien Tsai; Yann-Jang Chen; Tu-Lai Yew; Ling-Lan Chen; Jir-You Wang; Chao-Hua Chiu; Shih-Chieh Hung
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

Review 6.  Nontraumatic osteonecrosis of the femoral head: ten years later.

Authors:  Michael A Mont; Lynne C Jones; David S Hungerford
Journal:  J Bone Joint Surg Am       Date:  2006-05       Impact factor: 5.284

7.  Steroid effects on osteogenesis through mesenchymal cell gene expression.

Authors:  Xudong Li; Li Jin; Quanjun Cui; Gwo-Jaw Wang; Gary Balian
Journal:  Osteoporos Int       Date:  2004-06-15       Impact factor: 4.507

Review 8.  Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head.

Authors:  Lars Rackwitz; Lars Eden; Stephan Reppenhagen; Johannes C Reichert; Franz Jakob; Heike Walles; Oliver Pullig; Rocky S Tuan; Maximilian Rudert; Ulrich Nöth
Journal:  Stem Cell Res Ther       Date:  2012-02-22       Impact factor: 6.832

9.  Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone.

Authors:  L Qin; G Zhang; H Sheng; K W Yeung; H Y Yeung; C W Chan; W H Cheung; J Griffith; K H Chiu; K S Leung
Journal:  Bone       Date:  2006-06-12       Impact factor: 4.398

Review 10.  Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF.

Authors:  Ernestina Schipani; Christa Maes; Geert Carmeliet; Gregg L Semenza
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

View more
  9 in total

1.  Special manifestations and treatment of rare cases of snoring with special facial features and hearing loss in children.

Authors:  Jiali Wu; Xiaoli Li; Shumei Chen
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

Review 2.  Avascular Necrosis of the Femoral Head: Are Any Genes Involved?

Authors:  Farzaneh Pouya; Mohammad Amin Kerachian
Journal:  Arch Bone Jt Surg       Date:  2015-07

3.  miR-27a attenuates adipogenesis and promotes osteogenesis in steroid-induced rat BMSCs by targeting PPARγ and GREM1.

Authors:  Chenxi Gu; Yan Xu; Shanfeng Zhang; Hongya Guan; Shi Song; Xiuli Wang; Yisheng Wang; Yuebai Li; Guoqiang Zhao
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

4.  BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model.

Authors:  Na Yuan; Jia Li; Meng Li; Wenchen Ji; Zhaogang Ge; Lihong Fan; Kunzheng Wang
Journal:  BMC Musculoskelet Disord       Date:  2018-04-27       Impact factor: 2.362

5.  Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis.

Authors:  Tongtong Zhu; Yutao Cui; Mingran Zhang; Duoyi Zhao; Guangyao Liu; Jianxun Ding
Journal:  Bioact Mater       Date:  2020-04-17

6.  Ginsenoside Rb1 prevents steroid‑induced avascular necrosis of the femoral head through the bone morphogenetic protein‑2 and vascular endothelial growth factor pathway.

Authors:  Junwu Ye; Daiqin Wei; Lin Peng; Tianmin Chang
Journal:  Mol Med Rep       Date:  2019-08-06       Impact factor: 2.952

7.  Study on the molecular mechanism of BuShenHuoXue capsule in treatment of steroid-induced osteonecrosis of the femoral head.

Authors:  Jia-Cheng Li; Xue-Zhen Liang; Di Luo; Bo-Zhao Yan; Jin-Bao Liu; Gang Li
Journal:  Ann Transl Med       Date:  2020-12

8.  The protective effect of PFTα on alcohol-induced osteonecrosis of the femoral head.

Authors:  Yi-Xuan Chen; Dao-Yu Zhu; Jun-Hui Yin; Wen-Jing Yin; Yue-Lei Zhang; Hao Ding; Xiao-Wei Yu; Jiong Mei; You-Shui Gao; Chang-Qing Zhang
Journal:  Oncotarget       Date:  2017-07-11

9.  Effects of erythropoietin for precaution of steroid-induced femoral head necrosis in rats.

Authors:  Yong-Qing Yan; Qing-Jiang Pang; Ren-Jie Xu
Journal:  BMC Musculoskelet Disord       Date:  2018-08-07       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.